加载中
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
NASDAQFinancial ServicesShell Companies
最新数据
US$10.85
US$0.00 · 0.00%
前收盘价
US$10.85
US$0.00 · 0.00%
盘中时间采用ET。市场数据可能有所延迟。
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
日内区间
当前US$10.85
52周区间
当前US$10.85
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
48
合理估值
情绪
56
多空交织
风险
8
低风险
动量
40
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
日内区间
当前US$10.85
52周区间
当前US$10.85
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 |
|---|---|---|
| 销售、一般及管理费用 | 281.6万 USD | 479.73 USD |
| 营业费用 | 281.6万 USD | 479.73 USD |
| 利息收入 | 875.67万 USD | — |
| 折旧和摊销 | — | 47.97万 USD |
| 营业利润 | −281.6万 USD | −479 USD |
| 净利润 | 594.06万 USD | −479 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
